SOHM INC (SHMN)
SHMN moved a median of 0.00% 30 minutes after news, and 0.00% by the close. How SHMN actually reacts to news — the realized, point-in-time move the market made, measured across 35 labeled events over the last three years with zero look-ahead.
SHMN’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 19% | 26 |
| 30-min | 0.00% | 31% | 29 |
| 60-min | 0.00% | 37% | 30 |
| to close | 0.00% | 40% | 35 |
| Middle 50% of SHMN reactions | 0.00% to +8.33% |
|---|---|
| Median reaction (30-min) | 0.00% |
| Measured reactions | 35 |
Half of all SOHM INC news events land between +0.00% and +8.33% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when SHMN moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to SHMN's baseline. Nothing else.
Recent SHMN events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| SOHM Inc. Releases White Paper on ABBIE, a Cas9-Guided Integrase Enabling Stable Gene Integration and Creation of SKOV3-GYS1 Cell Line for Drug Discovery | Press release | ACCESS Newswire | +20.00% | +0.00% | |
| SOHM Notes FDA's Evolving Gene-Editing Framework in Context of Ongoing ABBIE Platform Development | Press release | ACCESS Newswire | +0.00% | +0.00% | |
| SOHM, Inc. Announces Allowance of Another Divisional Patent in the Republic of South Korea | Press release | ACCESS Newswire | -5.88% | -29.41% | |
| SOHM, Inc., Moving and Expanding Commercialization Capabilities with its New Vista, CA Facility | Press release | ACCESS Newswire | +0.00% | +0.00% | |
| SOHM Achieves Breakthrough with ABBIE Gene Editing Platform, Advancing Strategic Partnership and Licensing Opportunities | Press release | ACCESS Newswire | — | +25.00% | |
| SOHM, Inc. Launches New User-Friendly Website to Enhance Customer, Investor Experience and Engagement | Press release | ACCESS Newswire | +0.00% | +0.00% | |
| SOHM, Inc. Appoints Ravi Kapoor as an Independent Director | Press release | ACCESS Newswire | +20.00% | +20.00% | |
| SOHM, Inc. Sets Strategic Goals to Enter Biotechnology-Driven Cosmeceuticals Market | Press release | ACCESS Newswire | +0.00% | -10.00% | |
| SOHM Inc. Welcomes Dr. Larissa Karnaoukhova as New Vice President of Operations | Press release | ACCESS Newswire | — | +0.00% | |
| SOHM Inc. Welcomes Dr. Lucia Piccotti to Offer Expert Guidance on Cosmeceutical and Personal Health Product Research and Development | Press release | ACCESS Newswire | — | -12.50% | |
| SOHM, Inc., Unveils Genetically Engineered Ovarian Cancer Cell Line Using ABBIE(TM) Platform to Accelerate GYS1 Drug Discovery | Press release | ACCESS Newswire | -11.11% | +0.00% | |
| Dr. Leonardo Mirandola Joins SOHM, Inc. as an Advisory Board to Advance CAR-T Cell Projects Toward Clinical Trials and Commercialization | Press release | ACCESS Newswire | — | +0.00% | |
| SOHM Inc. Awarded European Patent for Innovative ABBIE Genome Editing Technology | Press release | ACCESS Newswire | +0.00% | +0.00% | |
| SOHM, Inc. Agrees to Licensing for Investigational and Pre-Clinical Studies for Groundbreaking ABBIE Genome Editing Technology for CAR-T Cell Cancer Therapies | Press release | ACCESS Newswire | +0.00% | +11.11% | |
| SOHM, Inc. Announces Patent Allowance/Approval in South Korea | Press release | ACCESS Newswire | +0.00% | -11.11% | |
| SOHM, Inc. Shares an Exciting Expansion and Upcoming Presentation on ABBIE | Press release | ACCESS Newswire | — | +7.14% | |
| SOHM, Inc. Launches New AI Team to Advance ABBIE System and Genome Editing Innovations | Press release | ACCESS Newswire | +14.29% | +7.14% | |
| SOHM, Inc. Shares Groundbreaking Findings in ABBIE Technology | Press release | ACCESS Newswire | +0.00% | +0.00% | |
| SOHM, Inc. Announce Dr. Wei Zhu Onboard as Senior Marketing and Sales Consultant | Press release | Accesswire | +0.00% | +5.56% | |
| SOHM, Inc. Announces Allowances Of Japanese Patent Claims Received from Japan's Patent Office (???, Tokkyocho, JPO) Protecting Transformative SOHM-ABBIE Genome Edited, SAGE Recombinant-Organisms, -Cells, -Secretomes, -Exosomes | Press release | Accesswire | +0.00% | +0.00% | |
| SOHM, Inc. Announce Dr. David Zarling Onboard as Senior Product Development Advisor | Press release | Accesswire | — | +0.00% | |
| SOHM, Inc. Continues to Build its IP Portfolio in the Gene Editing and Cell Engineering Space | Press release | Accesswire | — | +22.22% | |
| SOHM, Inc. has Received ABBIE Technology Kits' Pre-Launch Pre-Orders | Press release | Accesswire | +0.00% | +0.00% | |
| SOHM, Inc., Announce Dr. Tetsuya Kawamura Ph. D. Joined as a Cell Engineer and Biochemist | Press release | Accesswire | — | -5.26% | |
| SOHM, Inc. has signed the Manufacturing and Supply of Skincare Topical Products with New Export Customers | Press release | Accesswire | +0.00% | +0.00% | |
| SOHM, Inc., Announce a New Collaboration and Joins Forces with Stanford University | Press release | Accesswire | +0.00% | +10.00% | |
| SOHM, Inc. Announces its ABBIE Genome Editing Technology Successfully Engineered a T-cell immunotherapy from a Healthy Human Donor | Press release | Accesswire | +26.32% | +26.32% | |
| SOHM, Inc., Targets Revolutionary New ABBIE Genome Editing Kits for Q3, 2024 | Press release | GlobeNewswire | +15.00% | +20.00% | |
| SOHM, Inc. and Coastar Therapeutics Sign MoU and Announce Collaboration to Revolutionize Genome Editing Using Red Blood Cell Membrane Derived Carriers | Press release | GlobeNewswire | — | +10.00% | |
| SOHM Files Provisional Patent on ABBIE’s ‘Smart Gene-Editing’ That Uses Latest Enzymes and Guide RNA to Resolve Off-Target Gene-Editing Limitations | Press release | GlobeNewswire | +0.00% | +35.71% | |
| SOHM Announces Business Outlook for 2024 | Press release | GlobeNewswire | -13.33% | -6.67% | |
| SOHM Announces New CDMO GMP Manufacturing Facility in Carlsbad, California | Press release | GlobeNewswire | -7.14% | -7.14% | |
| SOHM OTC Self-care Launches Suite of 13 New SOHM Nutrients’ Brand Chewables | Press release | GlobeNewswire | +0.00% | +7.69% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the SHMN section they belong to.
Where else SHMN is measured.
SHMN earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Zynerba Pharmaceuticals, Inc. (ZYNE) | 36 | +0.39% | 71% |
| BITCOIN GROUP SE (BTGGF) | 35 | 0.00% | 14% |
| ECGI HOLDINGS INC (ECGI) | 34 | 0.00% | 30% |
| Emmis Acquisition Corp. - Class A Ordinary Share (EMIS) | 34 | 0.00% | 0% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is SOHM INC's median reaction calculated?
Every labeled SHMN news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 35 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 31% of SHMN's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does SHMN's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.